Find what AI can’t reach, from novel peptides to new materials
Want to know how to gain quantum advantage over the computational hurdles of molecular exploration? And how to do this today, on the same Python frameworks you already use?
Join a small, invite-only group of Pharma and Life Sciences leaders for a moderated roundtable on what quantum-enhanced discovery looks like, with benchmark results from NVIDIA’s Proteina models.
Be one of the first to visit Digital Realty’s Innovation Lab in London to see the newly installed photonic quantum accelerator: ORCA Computing’s PT-3.
Validated results, not a future promise
What quantum-accelerated models have already delivered
79%
of quantum-designed peptides confirmed as potent binders in vitro, across all three tested alleles
2×
the anomaly-detection rate at zero false positives in continuous bioprocessing
+49%
more valid and unique molecules than the classical baseline on the QM9 benchmark
“Being able to bring quantum computing alongside classical methods opens up far more of that space to search…”
Peer to peer discussion
Deliberately kept small — C-suite and senior leaders from big Pharma and Life Sciences organisations.
Arrivals & networking
Coffee and pastries in the DRIL Executive Briefing Centre.
Moderated roundtable discussion
Around 60 minutes, moderated by Phil Carvil from the Science and Technology Facilities Council
DRIL tour & PT-3 demo
Led by Nick Portch, Digital Realty and James Fletcher, ORCA Computing
Who you’ll meet
Dr Phil Carvil
Head of North West Clusters
Nick Portch
Director, Healthcare and Life Sciences Business
Dr Richard Murray
CEO & Co founder
Esperanza Cuenca-Gómez
Developer Relations
Dr William Clements
Applications,
More on ORCA’s quantum applications
QUANTUM INSIDER: Quantum Companies Help Develop Hybrid AI for Immune Targeting Peptides
Hybrid quantum-classical de novo design of MHC-binding peptides
ORCA Computing, PCSS and Imperial College collaborate with NVIDIA to demonstrate a distributed quantum neural network in a hybrid HPC environment
Questions about the session?
Speak to our events team.
David Hall DPhil
Head of Delivery
Prof. Ian Walmsley is Chairman of the ORCA Computing Board and a leading figure in quantum optics, quantum memories and waveguide circuits. He is Provost of Imperial College, London, an Honorary Fellow at St Hugh's College, Oxford and a Fellow of the Royal Society, The Optical Society, the Institute of Physics and the American Physical Society. Previously, he was President of the Optical Society of America, Pro-Vice-Chancellor for Research and Innovation, Hooke Professor of Experimental Physics at the University of Oxford and Director of the NQIT (Networked Quantum Information Technologies) hub. Prof. Walmsley is recognised for developing the SPIDER technique for characterising ultra-fast laser pulses.
Energy
Enhance renewable energy optimisation and accelerate the development of biofuels.
Where Quantum Computing can help
Investigating molecular structures is an important pursuit in computational chemistry, especially in fields likes biofuel formulation, material innovation, and pharmaceutical development where research acceleration is critical. The specific problem considered here is significant across the energy industry, as molecule’s possible structures directly determine many of its physical and chemical traits. However, the vast array of possible configurations and high computational requirements make it difficult for traditional methods to find low-energy conformations for certain molecules.
ORCA in Action
ORCA partnered has with bp to explore a hybrid quantum-classical approach using generative adversarial network (GAN) algorithms. This approach aims to generate low-energy conformations of small and medium size hydrocarbon molecules, offering a potential solution to the computational hurdles faced in molecular exploration.